Sana Biotechnology, Inc. (SANA) Tops Q1 EPS by 4c

Sana Biotechnology, Inc. (NASDAQ: SANA) reported Q1 EPS of ($0.43), $0.04 better than the analyst estimate of ($0.47).

For earnings history and earnings-related data on Sana Biotechnology, Inc. (SANA) click here.

You May Also Be Interested In

• Micron surges 5.5% on blockbuster Anthropic AI deal ahead of earnings
• Assurant (AIZ) is Piper Sandler's Weekly Focus Idea
• Sun Communities names Ileana McAlary as general counsel and EVP